• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“类肽”CCK-B拮抗剂的修饰以探究CCK-B激动剂活性的要求。

Modification of "peptoid" CCK-B antagonists to probe requirements for CCK-B agonist activity.

作者信息

Davey A E, Horwell D C

机构信息

Parke-Davis Neurosciences Research Centre, Addenbrooke's Hospital Site, Cambridge, U.K.

出版信息

Bioorg Med Chem. 1993 Jul;1(1):45-58. doi: 10.1016/s0968-0896(00)82102-1.

DOI:10.1016/s0968-0896(00)82102-1
PMID:8081837
Abstract

This paper describes the use of the non-peptidal N-(2-adamantyloxycarbonyl)-alpha-methyl tryptophan phenylethylamide template of the "peptoid" CCK B antagonist compounds 1 as a basis to probe the functional group requirements of the CCK B receptor in order to produce an agonist response. Comparison of the peptoid template with inter-group distances in a fully extended conformation of the endogenous CCK-B agonist CCK 30-33 led to the design of a series of compounds 2 containing additional Ph, COOH and CONH2, functions at distances from the Trp indole ring that are able to mimic those in the natural ligand. The effect of these modifications was then assessed by measurement of CCK B binding affinities and potential agonist efficacy was investigated by comparison with contraction of guinea-pig isolated stomach corpus muscle strip stimulated by the CCK-B agonist pentagastrin. All compounds showed sub-micromolar binding affinities with each series displaying discernible dependence on intermediate chain length. All compounds (except 2f) were shown to be good CCK B antagonists; no compounds showed significant agonist activity up to a concentration of 1 microM.

摘要

本文描述了使用“类肽”CCK B拮抗剂化合物1的非肽类N-(2-金刚烷氧基羰基)-α-甲基色氨酸苯乙酰胺模板作为基础,来探究CCK B受体的官能团需求,以产生激动剂反应。将类肽模板与内源性CCK-B激动剂CCK 30-33完全伸展构象中的基团间距离进行比较,从而设计出一系列化合物2,这些化合物在距色氨酸吲哚环一定距离处含有额外的苯基、羧基和氨基甲酰基官能团,能够模拟天然配体中的相应官能团。然后通过测量CCK B结合亲和力来评估这些修饰的效果,并通过与CCK-B激动剂五肽胃泌素刺激的豚鼠离体胃体肌条收缩情况进行比较,来研究潜在的激动剂效力。所有化合物均表现出亚微摩尔级的结合亲和力,且每个系列对中间链长度都有明显的依赖性。所有化合物(除2f外)均显示为良好的CCK B拮抗剂;在浓度高达1 microM时,没有化合物表现出显著的激动剂活性。

相似文献

1
Modification of "peptoid" CCK-B antagonists to probe requirements for CCK-B agonist activity.“类肽”CCK-B拮抗剂的修饰以探究CCK-B激动剂活性的要求。
Bioorg Med Chem. 1993 Jul;1(1):45-58. doi: 10.1016/s0968-0896(00)82102-1.
2
Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.利用选择性拮抗剂CI-988、L-365,260和地伐西匹对豚鼠胃新平滑肌制剂中的胆囊收缩素受体进行表征。
Br J Pharmacol. 1993 Aug;109(4):913-7. doi: 10.1111/j.1476-5381.1993.tb13707.x.
3
The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.利用受体脱敏分析豚鼠胃肌中与收缩相关的CCKA和CCKB/胃泌素受体。
Br J Pharmacol. 1995 Jan;114(2):339-48. doi: 10.1111/j.1476-5381.1995.tb13232.x.
4
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.胆囊收缩素类肽配体中受体选择性和功能活性的修饰。
J Med Chem. 1995 Aug 18;38(17):3384-90. doi: 10.1021/jm00017a022.
5
Second generation "peptoid" CCK-B receptor antagonists: identification and development of N-(adamantyloxycarbonyl)-alpha-methyl-(R)-tryptophan derivative (CI-1015) with an improved pharmacokinetic profile.第二代“类肽”CCK-B受体拮抗剂:具有改善药代动力学特征的N-(金刚烷氧基羰基)-α-甲基-(R)-色氨酸衍生物(CI-1015)的鉴定与开发。
J Med Chem. 1998 Jan 1;41(1):38-45. doi: 10.1021/jm970065l.
6
Properties of receptors for gastrin and CCK on gastric smooth muscle cells.胃平滑肌细胞上胃泌素和胆囊收缩素受体的特性
Am J Physiol. 1989 Jul;257(1 Pt 1):G73-9. doi: 10.1152/ajpgi.1989.257.1.G73.
7
[3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.[3H]PD 140376:一种用于豚鼠大脑皮层和胃黏膜中胆囊收缩素B/胃泌素受体的新型高选择性拮抗剂放射性配体。
Mol Pharmacol. 1993 Apr;43(4):595-602.
8
Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells.新型受限CCK - B拮抗剂的合成及生物学特性:对转染CHO细胞上CCK - B受体两种亲和状态的区分
J Med Chem. 1997 Nov 21;40(24):3947-56. doi: 10.1021/jm970439a.
9
Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.肽三维结构模拟物的开发:新型类肽胆囊收缩素受体拮抗剂的合理设计。
J Med Chem. 2000 Sep 21;43(19):3505-17. doi: 10.1021/jm000937a.
10
Endogenous CCK depresses contractile activity within the ascending myenteric reflex pathway of rat ileum.内源性胆囊收缩素会抑制大鼠回肠升支肌间反射通路内的收缩活动。
Neuropharmacology. 2003 Mar;44(4):524-32. doi: 10.1016/s0028-3908(03)00028-5.

引用本文的文献

1
The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.亲脂性“子弹”命中靶点:金刚烷衍生物的药物化学
Chem Rev. 2013 May 8;113(5):3516-604. doi: 10.1021/cr100264t. Epub 2013 Feb 25.